James Korolewicz

Efficacy and safety of frontline systemic therapy for advanced HCC: A network meta-analysis of landmark phase III trials

Claudia Angela Maria Fulgenzi, Bernhard Scheiner, James Korolewicz et al. · JHEP Reports · 2023 · 53 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +14

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): “Real World” Experience

Dimitra Rafailia Bakaloudi, Rafee Talukder, Genevieve Ihsiu Lin et al. · Clinical Genitourinary Cancer · 2023 · 27 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Baseline neutrophil-lymphocyte ratio and platelet-lymphocyte ratio appear predictive of immune treatment related toxicity in hepatocellular carcinoma

Sirish Dharmapuri, Umut Özbek, Hiren Jethra et al. · World Journal of Gastrointestinal Oncology · 2023 · 22 citations · Full text

Medicine, Hematology, Oncology +17

Neoadjuvant immunotherapy with ipilimumab plus nivolumab and radiologically and pathologically quantifiable responses through modulation of the tumour microenvironment in resectable hepatocellular carcinoma.

Antonio D’Alessio, Madhava Pai, Duncan Spalding et al. · Journal of Clinical Oncology · 2023 · 15 citations

Life Sciences, Immunology, Oncology +17

Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study

Vincent Joerg, Bernhard Scheiner, Antonio D ́Alessio et al. · Hepatology Communications · 2023 · 11 citations · Full text

Medicine, Oncology, Pharmacology +16